ALKERMES | Egenkapital Og Reserver



Equity Capital And Reserves Endring Dato
AbbVie USD 3.32B 2.71B 2024-12
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
ALKERMES USD 1.46B 172.88M 2024-12
Amgen USD 5.88B 1.65B 2024-12
Biogen USD 16.72B 357.1M 2024-12
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
J&J USD 78.11B 6.62B 2025-03
Malin Corporation EUR 118.2M 8.7M 2024-06
Merck USD 46.31B 1.81B 2024-12
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Otsuka Holdings JPY 2.65T 85.39B 2025-03
Pfizer USD 88.2B 4.08B 2024-12
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



ALKERMES Egenkapital Og Reserver - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.